Pricing
  1. JP-listed companies
  2. JMS CO.,LTD.
  3. Financials
  4. Earnings per share

JMS CO.,LTD.【JP:7702】

Market cap
¥10.7B
P/E ratio
-13.3x
JMS manufactures and sells medical devices and pharmaceuticals globally, serving healthcare markets across Asia, Europe and the Americas.
SummaryFinancialsDividendsHistorySegmentsOwnershipWorkforce
Period EndEarnings per share (JPY)YoY (%)
Mar 31, 20253.7-346.62%
Mar 31, 2024-1.5-112.87%
Mar 31, 202311.5-66.01%
Mar 31, 202233.8-52.44%
Mar 31, 202171.1-12.32%
Mar 31, 202081.1+70.46%
Mar 31, 201947.6+83.67%
Mar 31, 201825.9+6.80%
Mar 31, 201724.3+56.72%
Mar 31, 201615.5+443.16%
Mar 31, 20152.9-32.94%
Mar 31, 20144.3-85.55%
Mar 31, 201329.4+34.66%
Mar 31, 201221.8

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)